Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Why Acorda Therapeutics Inc and Forward Pharma A/S Got Crushed Today [The Motley Fool]

Acorda Therapeutics, Inc. (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
Company Research Source: The Motley Fool
Patent battles end poorly for both companies. Brian Orelli ( TMFBiologyFool ) Mar 31, 2017 at 5:14PM What happened Forward Pharma ( NASDAQ:FWP ) ended the day down 19.9% while Acorda Therapeutics ( NASDAQ:ACOR ) didn't fare any better, down 21.5%, after investors received word that the companies had lost separate patent battles. So what A U.S. patent board ruled against Forward Pharma's claim that Biogen 's ( NASDAQ:BIIB ) multiple sclerosis drug Tecfidera infringed on patents held by Forward Pharma. In January, Forward Pharma and Biogen agreed to a settlement with a twist. Biogen agreed to pay Forward Pharma $1.25 billion upfront and to pay a royalty of 10% from January 1, 2021 to December 31, 2028, and a royalty of 20% from January 1, 2029 until the patent expired, assuming it had an exclusive right to Forward Pharma's patent. Show less Read more
Impact Snapshot
Event Time:
ACOR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
ACOR alerts

from News Quantified
Opt-in for
ACOR alerts

from News Quantified